Skip to content
Monday 10 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
0.00%
CAC 40
8,714.93
0.00%
STOXX 50
6,523.86
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

vaccines

  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma

    Pharma giant GSK has sealed a $10bn deal to snap up Boston-based biopharmaceutical company Nuvalent. The FTSE 100 titan said it will pay $124 per share in cash in the agreement, marking a 40 per cent premium over what Nuvalent’s stock was trading at just before this announcement. The deal is expected to officially close [...]

    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Government scrambles to swerve Trump pharma tariffs

    Politics

    A race against time is underway to shield the UK pharmaceutical sector from potentially swinging Trump tariffs on imported drugs.  As it stands, there is an exemption for pharmaceuticals on the baseline 10 per cent tariffs for goods coming into the US.  However, President Trump has warned that there will be tariffs on imported pharma [...]

    Despite these headwinds, mid-sized businesses are working to tackle the challenges they face and remain optimistic. Ahead of Government’s plans to publish a Small Business Strategy later this year, the majority (95%) expect the strategy's focus on growing smaller firms to benefit them.
  • Would you volunteer to get yourself infected with flu in Canary Wharf?

    Opinion

    For £3,000 you can opt to spend a week helping to create the next generations of vaccines at the world’s largest human challenge trial and quarantine facility – a minute’s walk from Canary Wharf, says Phoebe Arslanagić-Little In October I wrote in Morning Wire about human challenge trials – a medical research study that sees [...]

Trending Articles

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • PwC’s Embankment HQ to get major makeover ahead of Canary Wharf move

  • A tribute to wine legend Matthew Jukes by his friend Libby Brodie

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook